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Background: Type I interferons (IFN-Is) serve as mediators of antiviral innate immunity and also regulate adaptive
immune responses. The molecular mechanism that regulates virus-induced IFN-I production, particularly in
tissue-resident immune cells, is incompletely understood.
Results: Here we identified the E3 ubiquitin ligase Peli1 as a negative regulator of IFN-I induction in microglia,
innate immune cells of the central nervous system (CNS). Peli1 deficiency profoundly promoted IFN-β expression in
microglia in response to in vitro stimulation by toll-like receptor (TLR) ligands or a CNS-tropic virus, the vascular
stomatitis virus (VSV). Upon intranasal infection with VSV, the Peli1-deficient mice displayed heightened in vivo IFN-I
responses in the CNS, coupled with reduced brain viral titer and increased survival rate.
Conclusions: These results establish Peli1 as an innate immune regulator in the CNS that modulates the threshold
of IFN-I responses against viral infections.
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Type I interferons (IFN-Is) provide one of the body’s pri-
mary defense systems against viral infections. The high
susceptibility of type I IFN receptor (IFNAR)-deficient
mice to infection by a variety of viruses provides strong
evidence for the major role of the IFN system in anti-
viral innate immunity [1]. In addition, IFN-Is also play
an important role in modulating the development of
adaptive immune responses [2]. Induction of IFN-Is is
mediated by pattern-recognition receptors (PRRs), such
as the toll-like receptors (TLRs) and the cytoplasmic
RIG-I-like receptors (RLRs). The PRRs can efficiently de-
tect viral infections through recognition of molecular
patterns associated with viral genomes and replication
products [3–5]. The TLR family is composed of mem-
bers that signal through two major adaptors, MyD88
and TRIF. The TRIF-dependent TLRs, TLR3 and TLR4,
as well as the RLRs stimulate Ifnb gene expression via
activation of two homologous kinases, TBK1 and IKKε.* Correspondence: ssun@mdanderson.org
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factor IRF-3, which causes IRF-3 dimerization and trans-
location to the nucleus, where it mediates the transacti-
vation of the Ifnb gene [6, 7].
Although IFN-I induction has been extensively studied
using macrophages and dendritic cells, IFN-Is are also
produced by tissue resident cells and play a tissue-
specific role in mediating antiviral innate immunity and
regulating immune homeostasis [2, 8]. In particular, the
microglia are resident macrophages of the central ner-
vous system (CNS) that are important for immune re-
sponses against infections in the CNS [9, 10]. These
cells, which seed the parenchyma of the CNS early
during embryonic development, express various PRRs,
including the TLRs and RLRs, and become rapidly acti-
vated upon detection of infections and tissue damage
[11–13]. In addition to mediating antiviral innate im-
munity, IFN-Is play an important role in regulating
other types of immune responses, thereby exerting
pathogenic or protective roles in the CNS [13]. Thus,
the production of IFN-Is is subject to both positive and
negative mechanisms of regulation.
Despite the extensive studies on the core components
of the IFN-I induction pathway, the regulatory factors
are still poorly defined. We have recently shown that thele distributed under the terms of the Creative Commons Attribution License
which permits unrestricted use, distribution, and reproduction in any medium,
. The Creative Commons Public Domain Dedication waiver (http://
) applies to the data made available in this article, unless otherwise stated.
Xiao et al. Cell & Bioscience  (2015) 5:34 Page 2 of 8E3 ubiquitin ligase Peli1 (also called Pellino1) is required
for TLR-stimulated proinflammatory cytokine expression
in microglia, although its role in regulating IFN-I
expression has remained unclear [14]. Unlike peripheral
macrophages, which express both Peli1 and its homo-
logs, Peli2 and Peli3, microglia predominantly express
Peli1 [14]. We found in the present study that in con-
trast to its positive role in regulating proinflammatory
cytokine induction, Peli1 is a potent negative regulator
of IFN-I induction by TLR ligands and viruses. In
response to intranasal infection by a neurotropic virus,
vascular stomatitis virus (VSV), the Peli1-deficient mice
expressed elevated levels of IFNα and IFN-β in the
microglia of CNS, coupled with reduced brain viral titer
and increased rate of mouse survival. These findings
establish Peli1 as a negative regulator of IFN-I induction
and antiviral innate immunity in the CNS.
Results
Peli1 negatively regulates TLR-mediated IFN-β induction
in microglia
To investigate the role of Peli1 in regulating IFN-I
induction, we prepared primary BMDM and microgliaFig. 1 Peli1 negatively regulates TLR-mediated IFN-β induction in microgl
genes in WT and Peli1-KO bone marrow-derived macrophages (BMDM) (a
TLRs: TLR4 (LPS, 100 ng/ml), TLR9 (CpG, 2.5 μM), TLR7/8 (R837, 1 μg/ml), TL
and **P < 0.01. d IB analysis of phosphorylated (P-) and total TBK1 and IKK
LPS (100 ng/ml)from Peli1-KO mice and wildtype (WT) control mice. In
contrast to the BMDMs expressing an E3 ligase-
defective Peli1 mutant [15], the Peli1-KO BMDMs did
not show significant reduction in LPS-stimulated IFN-β
induction (Fig. 1a). On the other hand, the Peli1 defi-
ciency reduced the induction of several proinflammatory
cytokine genes, likely due to the role of Peli1 in mediating
TRIF-dependent NF-κB activation [16]. Since BMDMs
express different Peli family members at comparably levels
[17], Peli1 might have functional redundancy with the
other members. We thus examined the role of Peli1 in
IFN-β regulation in microglia, in which Peli1 represents
the predominant Peli family member [14]. As we previ-
ously reported [14], the Peli1 deficiency in microglia
profoundly inhibited the induction of several proinflam-
matory cytokines by LPS and other TLR ligands (Fig. 1b,
c). To our surprise, the loss of Peli1 in microglia resulted a
striking upregulation of IFN-β induction stimulated by
LPS as well as by several other TLR ligands (Fig. 1b, c).
These results suggest that Peli1 functions as a negative
regulator of IFN-β induction in microglia.
To delineate the molecular mechanism by which Peli1
negatively regulates IFN-β induction, we examined theia. a-c QPCR analysis of relative mRNA expression for the indicated
) or microglia (b,c) stimulated with the indicated ligands for different
R1/2 (Pam3CSK4, 1 μg/ml), and TLR3 (poly(I:C), 10 μg/ml). *P < 0.05
ε in whole-cell lysates of WT or Peli1-KO microglia stimulated with
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IFN-stimulating kinases, TBK1 and IKKε, based on their
phosphorylation. Stimulation of WT microglia by LPS
led to the phosphorylation of both TBK1 and IKKε
(Fig. 1d). Moreover, the Peli1 deficiency substantially
enhanced the LPS-stimulated TBK1/IKKε phosphoryl-
ation. These results suggest that Peli1 negatively regu-
lates TLR-mediated IFN-I induction through inhibition
of signaling events involved in the activation of TBK1
and IKKε.
Peli1 deficiency promotes IFN-β production in brain upon
LPS stimulation
To examine the in vivo role of Peli1 in regulating IFN-I
induction, we stereotaxically injected LPS into cerebro-
spinal fluid (CSF) and examined the IFN-I induction in
the mouse brain. We found that injection of LPS stimu-
lated the expression of Peli1 in the brain (Fig. 2a). Con-
sistent with our previous work [14], the LPS-stimulated
induction of several proinflammatory cytokines was
significantly decreased in the brain of Peli1-KO mice, as
compared to that of the WT mice. In contrast, the Peli1
deficiency substantially enhanced the Ifnb gene induc-
tion following the LPS injection (Fig. 2b). Similarly,
ELISA also revealed an elevated level of IFN-β protein in
the whole brain homogenization of the LPS-injected
Peli1-deficient mice (Fig. 2c). These results are consist-
ent with the in vitro studies using the Peli1-deficient
microglia (Fig. 1b) and further establish an in vivo role
for Peli1 in negatively regulating IFN-β production in
the brain.Fig. 2 Peli1 deficiency promotes IFN-β production in brain upon LPS stimu
indicated genes in the brains of WT and Peli1-KO mice that were stereotax
brain homogenate of WT and Peli1-KO mice that were stereotaxically injectPeli1 negatively regulates VSV-mediated IFN-I expression
Microglia serve as a major type of CNS-resident cells
that respond to viral infections [18–20]. To investigate
the role of Peli1 in regulating antiviral immune re-
sponses in microglia, we employed VSV, a virus known
to infect microglia and CNS [21, 22]. Infection of micro-
glia with VSV led to the induction of both IFN-Is and
proinflammatory cytokines. Furthermore, Peli1 deficiency
in microglia significantly enhanced the induction of Ifna
and Ifnb genes and concomitantly inhibited the induction
of the Il6 and Tnf genes (Fig. 3a). To examine the func-
tional role of Peli1 in mediating anti-VSV host defense,
we infected the Peli1-deficient and WT microglia with
VSV-GFP, which allows quantification of the infected
cells by flow cytometry based GFP expression. Consist-
ent with their hyper-production of IFN-Is, the Peli1-KO
microglia were substantially more resistant to VSV in-
fection, as evidenced by the much lower level of VSV-
infected cells (Fig. 3b). These results suggest that Peli1
negatively regulate anti-VSV immune responses in
microglia.
Peli1 deficiency promotes host defense against viral
infection in CNS
To examine the in vivo role of Peli1 in regulating anti-
viral function, we challenged the Peli1-KO and WT con-
trol mice with VSV through intranasal injection, a route
that is known to lead to CNS infection [21, 23]. Com-
pared with the WT control mice, the Peli1-KO mice
were remarkably more resistant to VSV infection, as re-
vealed by the much improved survival rate (Fig. 4a). Thislation. a-c QPCR analysis of relative mRNA expression for Peli1 and the
ically injected with PBS or LPS. c ELISA of the indicated cytokines in the
ed with PBS or LPS. *P < 0.05; **P <0.01
Fig. 3 Peli1 negatively regulate VSV-mediated IFN-I induction. a QPCR analysis of the indicated genes in WT and Peli1-KO microglia infected with
VSV in vitro. b Flow cytometry analysis of the percentage of VSV-GFP-infected WT and Peli1-KO microglia. Numbers in the panels represent the
percentage of GFP+ (VSV-infected) microglia. *P < 0.05; **P <0.01
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nificantly enhanced expression of IFN-Is in the brain
(Fig. 4b), and remarkably lower VSV titer in the homog-
enates of the olfactory bulb (OB) and brain (Fig. 4c, d).
To identify the neural cell linage that is responsible for
the production of IFN-Is against virus infection, we in-
fected WT and Peli1-KO mice with VSV-GFP through
intracranial injection, and then isolated different type of
neural cells by FACS sorting for QPCR analysis. The
microglia isolated from VSV-GFP-infected Peli1-KO
mice expressed a significantly higher level of Ifna and
Ifnb than the microglia derived from the VSV-GFP-
infected WT mice (Fig. 5a). In contrast, neither astro-
cytes nor neurons, isolated from the VSV-GFP-infected
WT and Peli1-KO mice, had significant differences in
IFN-I expression (Fig. 5b, c). We also found that the
Peli1-KO microglia exhibited significantly reduced GFPexpression compared to the WT microglia, suggesting
augmented anti-VSV function of the Peli1-KO microglia
(Fig. 5d, e). This result was consistent with that obtained
with the in vitro microglial infection model (Fig. 3b).
Taken together, these data suggest that Peli1 negatively
regulates CNS host defense against VSV infection through
suppressing IFN-I production in microglia.
Discussion
In the present study, we identified the E3 ubiquitin
ligase Peli1 as a pivotal negative regulator of IFN-I in-
duction in microglia of the CNS. The Peli1 deficiency
profoundly promoted the induction of IFN-Is in micro-
glia in response to stimulation by the ligands of TRIF-
dependent TLRs, poly(I:C) and LPS, or infection by the
RNA virus VSV. The hyper-production of IFN-Is by the
Peli1-deficient microglia was associated with enhanced
Fig. 4 Peli1 deficiency promotes host defense against viral infection in the CNS. a Survival of WT (n = 7) and Peli1-KO (n = 6) mice after intranasal
infection with 1 × 107 pfu of VSV. b QPCR analysis of the indicated genes in the brain of WT and Peli1-KO mice 24 h after intranasal infection with
1 × 107 pfu of VSV. c, d VSV titer of the OB (c) and brain (d) in WT and Peli1-KO mice on day two after VSV intranasal infection, plotted as pfu/g
tissue with mean on log scale
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were also more resistant to intranasal infection with
VSV, coupled with heightened production of IFN-Is in
the CNS.
The microglia-specific role of Peli1 in negatively regu-
lating IFN-I expression is at least partially due to its cell-
specific expression. We have previously shown that Peli1
deficiency has no appreciable effect on the induction of
IFN-Is in peripheral innate immune cells and MEFs [16].
Interestingly, however, a Peli1 knockin study demon-
strates that IFN-β induction is attenuated in myeloid
cells and MEFs expressing a Peli1 mutant lacking E3
ligase activity [15]. It is currently unclear whether this
discrepancy is due to cell-type specific functions of Peli1
or the differences between expression of a Peli1 mutant
and complete ablation of Peli1. One possibility is that
the E3-defective Peli1 may exert an active role by bind-
ing to, and modulate the function of, other Peli family
members. In this regard, Peli3 serves as a negative
regulator of IFN-I induction by TLR3 and viruses [24].
Future studies will examine whether the mutant form of
Peli1 is able to bind Peli3 and promote the negative role
of Peli3 in IFN-I regulation. Notwithstanding, our
present study identified Peli1 as a negative regulator of
IFN-I induction in microglia in response to TLR stimu-
lation and VSV infection. In these CNS resident macro-
phages, Peli1 is the predominant Peli family member[14], which allows us to investigate Peli1 function with-
out a major influence from other Peli family members.
Our findings suggest that Peli1 and Peli3 share similar
functions in the regulation of IFN-I induction, which is
consistent with the high level of structural homology
between these two Peli family members.
Although how precisely Peli1 negatively regulates IFN-I
induction in microglia remains to be further investigated,
our present study suggests that Peli1 controls a signaling
step that mediates activation of the protein kinases TBK1
and IKKε. Peli1-deficient microglia were hyperresponsive
to LPS stimulation in the activation of both TBK1 and
IKKε. Previous studies have identified TRAF3 a central
mediator of IFN-I induction by both TLR ligands and
viruses [25, 26]. Notably, we have previously shown that
the Peli1 deficiency causes accumulation of TRAF3 in
microglia following TLR stimulation [14]. It is thus
possible that the accumulated TRAF3 expression in Peli1-
deficient microglia may contribute to the enhanced activa-
tion of TBK1 and IKKε and hyper-induction of IFN-Is.
This possibility will be examined in future studies.
Conclusions
The findings of the present study establish Peli1 as a
negative regulator of IFN-I induction in microglia and
an important modulator of antiviral immune responses
in the CNS.
Fig. 5 Peli1 deficiency promotes IFN-I expression and anti-viral defense by microglia in an in vivo model of VSV infection. a-c QPCR analysis of
the indicated genes in FACS-sorted microglia, astrocytes, and neuron derived from the WT or Peli1-KO mice 24 h after intracranial infection with
VSV-GFP (1 × 107 pfu). d,e Flow cytometric analysis of GFP expression in CD11b+ microglia isolated from the brain of WT or Peli1-KO mice 24 h
after intracranial infection with VSV-GFP (1 × 107 pfu). Data are presented as a representative plot (d) and summary graph of the percentage of
GFP+ microglia (b). *P < 0.05; **P < 0.01
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Mice
Peli1-deficient mice (on the C57BL/6 × 129/Sv back-
ground) have been described. Peli1+/− heterozygous mice
were bred to generate age-matched Peli1−/− (Peli1-KO)
and Peli1+/+ (WT) mice. Green fluorescence protein
(GFP) transgenic (C57BL/6-Tg(CAG-EGFP)10sb/J) mice
were from The Jackson Laboratory. Mice were maintained
in a specific pathogen-free facility, and all animal experi-
ments were in accordance with protocols approved by the
Institutional Animal Care and Use Committee of the
University of Texas MD Anderson Cancer Center.
Antibodies and reagents
Antibodies for TBK1 and phospho-TBK1 were pur-
chased from Cell Signaling Technology Inc. The anti-
IKKε and anti-phospho-IKKε antibodies were from
Santa Cruz and Millipore, respectively. LPS (derived
from Escherichia coli strain 0127:B8) was from Sigma-
Aldrich, poly(I:C) was from Amersham, CpG (1668)
was from TIB Molbio, Pam3CSK4 was from Alexis Bio-
chemicals, and R-837 was from Invivogen.Stereotaxic injection
We slowly injected PBS, LPS or VSV-GFP into the cere-
brospinal fluid (CSF) (AP, −0.4 mm; ML, −0.8 mm; and
DV, −2.5 mm) of Peli1-KO or wild-type control mice as
described previously [14].
BM chimeras
WT and Peli1-KO mice (8-weeks-old) were lethally irra-
diated (950 rads) and reconstituted with mononuclear
BM cells (1 × 107) from the GFP transgenic mice. After
8 weeks, the chimeric mice were immunized for EAE
induction as described previously [14].
Flow cytometry
Cell suspensions were subjected to flow cytometry analyses
as previously described using a LSRII flow cytometer [14].
Viruses and infections
VSV (Indiana strain) and VSV expressing GFP (VSV-GFP)
were provided by Glen Barber. For infections, 1 × 107 pfu
of VSV in 30 μl of endotoxin-free PBS was administered
in drops (~5 ml/drop) to isofluorane-anesthetized 8–12
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were monitored daily for disease symptoms and mortality.
In some experiment, mice were sacrificed 24 h after
virus infection, the brain were collected for RNA extrac-
tion or for preparation of neural cells by using Neural
Tissue Dissociation Kit (Miltenyi Biotech). The isolated
neural cells were subjected for flow cytometric analysis
or for FACS sorting of microglia (CD11b+), astrocyte
(GLAST-1+), and neuron (CD11b−CD31−GLAST1−O4−)
by using the Neuron isolation kit from Miltenyi Biotec.
Virus quantification
For quantification of infectious VSV in organs, mice were
anesthetized with pentobarbital (150 mg/kg). Organs were
snap-frozen in liquid nitrogen, weighed, pestle/tube-ho-
mogenized in 1 ml of PBS per brain or lung or 0.1 ml per
pair of olfactory bulbs, and virus was titered in 10-fold
serial dilutions on BHK21 cells by plaque assay. Results
are expressed as plaque-forming units (pfu) per gram of
tissue.
Primary microglia culture
Mixed glial cultures were prepared from 1- to 2-day-old
mice. In brief, after removing the meninges, brains were
dissociated by 0.25 % trypsin, and were filtered with a
40-μm mesh. Cells were cultured in DMEM supple-
mented with 10 % heat-inactivated fetal calf serum, 100
U/ml penicillin, and 100 mg/ml streptomycin. The cul-
ture medium was changed after 24 h and then every
3 days. Two weeks later, microglia were obtained by in-
tensive washing and shaking the culture (250 rpm) for
1 h at 37 °C. The purity of the microglia was >97 % as
determined by flow cytometry to measure the percent-
age of CD11b+ cells.
Quantitative RT-PCR
Real-time quantitative RT-PCR (qPCR) was performed
as described using gene-specific primer sets (Table 1).
Gene expression was assessed in triplicate and normal-
ized to a reference gene, Actb.Table 1 Gene-specific primers used for real-time PCR
assays







Actb CGTGAAAAGATGACCCAGATCA CGTGAAAAGATGACCCAGATCAImmunoblot (IB)
Primary microglia were stimulated with 100 ng/ml LPS
for the indicated time period and lysed in RIPA buffer.
The whole cell extract were separated via 8.25 % SDS-
PAGE, transferred to PVDF membranes, blocked and
subject to IB analysis.
Statistical analysis
One-way ANOVA, where applicable, was performed to
determine whether an overall statistically significant
change existed before the Student’s t-test to analyze the
difference between any two groups. Data are presented
as means ± SD. A P-value less than 0.05 is considered
statistically significant.
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